Prilosec Bioequivalence Study in healthy volunteers

Exclusion Criteria

• -History of any clinically important disease or disorder which, in the opinion of the Investigator, may either put the volunteer at risk because of participation in the
• study.
• - History or presence of gastrointestinal, hepatic, or renal disease or any other condition known to interfere with absorption, distribution, metabolism, or excretion
• of drugs.
• - Any clinically important illness, medical/surgical procedure, or trauma within 4 weeks of the first administration of investigational medicinal product (IMP).
• - Any clinically significant abnormalities in the physical examination, clinical laboratory values, 12-lead ECG, or vital signs, as judged by the Investigator.
• - Moderate to heavy smokers (more than 10 cigarettes per day or equivalent in tobacco-containing products).